.
MergerLinks Header Logo

Announced

Completed

OMERS, Goldman Sachs, AXA IM completed the acquisition of amedes from Antin for $1.75bn.

Financials

Edit Data
Transaction Value£1,278m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Friendly

Single Bidder

Private

Acquisition

Cross Border

Majority

Private Equity

holding company

Germany

health care services

Health Care Services

Completed

Synopsis

Edit

OMERS, an infrastructure investment company, Goldman Sachs Asset Management and AXA IM, an alternative investments provider, completed the acquisition of amedes, a provider of medical diagnostics services from Antin, for $1.75bn. “We are pleased to continue the extremely positive development of our specialist network with a new owner group that appreciates our medical performance and supports our growth potential in specialized diagnostics and therapy. The consortium would like to have a long-term commitment to amedes, share our strategic goals and rely on continuity in the course we have chosen . We are very grateful to Antin for the trust they have placed in amedes throughout their investment cycle. Together with Antin, we have achieved important strategic goals and expanded our position as a leading company for integrated special diagnostics and therapy," Wolf Frederic Kupatt, amedes CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US